Azienda ospedaliera "Bianchi-Melacrino-Morelli"

Recent papers from Azienda ospedaliera "Bianchi-Melacrino-Morelli"

1. Emergency MDCT in Internal Hernias: Short Reports Highlighting the Importance of Timely Surgical InterventionAnnali Italiani di Chirurgia · 2026
2. How to Measure Epicardial Adipose Tissue in Echocardiography, its Role in Cardiovascular Disease and the Results of the EPI-FAT SurveyJournal of Cardiovascular Echography · 2026
3. Xeruborbactam and Nacubactam, New Perspectives for β-Lactamase Inhibitors: A Narrative ReviewAntibiotics · 2026
4. Menin Inhibitors in Acute Myeloid Leukemia: From Molecular Rationale to Clinical PracticeJournal of Personalized Medicine · 2026
5. Ponatinib–Blinatumomab or Imatinib–Chemotherapy for Adult Ph-Positive ALLNew England Journal of Medicine · 2026
6. BCMA ‐Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical ManagementEuropean Journal Of Haematology · 2026
7. Sudden unexpected death in epilepsy: An Italian expert consensus statement on risk, mechanisms, prevention, and therapeutic strategiesEpilepsia Open · 2026
8. Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in ProgressOncoTargets and Therapy · 2026
9. A Comprehensive Review of the Underlying Mechanisms of Resistance and Therapeutic Options for DTR-PA in Bloodstream Infection and Pneumonia: A Clinical Vignette-Based ApproachMicroorganisms · 2026
10. Susceptibility, methodological discrepancies, heteroresistance, and iron acquisition-mediated cefiderocol resistance in Italian Pseudomonas aeruginosa: results from a multicenter prospective studyInternational Journal of Antimicrobial Agents · 2026
11. Primary mediastinal B-cell lymphoma: a nationwide real-life retrospective study of first-line treatment approaches in ItalyHaematologica · 2026
12. Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studiesHaematologica · 2026
13. Sequential transplantation of allogeneic hematopoietic stem cells and liver in x-linked hyper-IgM syndrome: the role of CMV prophylaxis with letermovirAnnals of Hematology · 2026
14. Pancreatic iron overload as a marker of endocrine complications in transfusion‐dependent thalassaemia: A multicentre studyBritish Journal of Haematology · 2026
15. Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flowCytometry Part B Clinical Cytometry · 2026
16. Aerosolized antifungal therapy in pulmonary fungal disease: pharmacology, drug delivery and emerging clinical applicationsFrontiers in Medicine · 2026
17. Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 studyBritish Journal of Haematology · 2026
18. Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and OutcomesHematology Reports · 2026
19. Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCyAmerican Journal of Hematology · 2026
20. DECREASE study: A European pool‐analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access ProgramsEpilepsia Open · 2026